7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Metabolic and Lifestyle-Related Heart Diseases
Many cases of heart disease are linked to metabolic and lifestyle-related factors that can be modified through conscious health choices. Conditions like diabetes, hypertension, and obesity disrupt normal metabolic functions and contribute to the gradual buildup of plaque in the arteries, leading to heart disease. By promoting lifestyle changes such as increased physical activity, balanced diets, and weight management, the risk of developing metabolic and lifestyle-related heart diseases can be greatly reduced. Public health initiatives focus on educating individuals about these lifestyle factors, empowering them to make informed choices. Ultimately, prevention through lifestyle modification plays a pivotal role in reducing the incidence and severity of these heart conditions.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Mekhman N Mamedov
National Research Center for Therapy and Preventive Medicine, Russian Federation
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain